The Investor's Podcast (We Study Billionaires)  - The Investor’s Podcast Network The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network

TIP857: S&P Global, Novo, Deckers Brands w/ Stig Brodersen, Tobias Carlisle, & Hari Ramachandra

Nov 1, 2026 · 1h 27m

Summary

In this episode, Stig Brodersen joins value investors Tobias Carlisle and Hari Ramachandra to pitch three stocks the market has fallen out of love with. Hari argues that Novo Nordisk is undervalued at 12x earnings despite competition from Eli Lilly, while Stig highlights S&P Global as a high-quality, moat-protected business with overblown AI disruption risks. Finally, Toby presents Deckers, the owner of Hoka and UGG, as a classic value pick trading at 11x earnings with significant net cash.

Topics discussed

Introduction and episode overview Novo Nordisk pitch: Background and market position Novo Nordisk: Valuation, risks, and pipeline Novo Nordisk: Competitive dynamics and innovation Sponsor breaks and AI regulation discussion S&P Global pitch: Business model and segments S&P Global: Risks, AI disruption, and valuation S&P Global: Insider buying and closing thoughts Deckers pitch: Business overview and capital allocation Deckers: Competitors, brand loyalty, and scenarios Deckers: Risks, tariffs, and final valuation Closing remarks and sign-off

More from The Investor's Podcast (We Study Billionaires) - The Investor’s Podcast Network

TIP863: S&P Global (SPGI): A Market Titan Goes on a Rare Sale w/ Shawn O’Malley & Daniel Mahncke
Nov 22, 2026
TIP862: Apple (AAPL): Is Apple Priced for a Massive Drawdown? w/ Daniel Mahncke & Shawn O'Malley
Nov 19, 2026
TIP861: Reddit (RDDT): Record Cash Flow, Collapsing Share Price w/ Kyle Grieve & Shawn O'Malley
Nov 15, 2026
TIP860: Canadian Pacific Kansas City Limited (CP.TO): Irreplaceable Moat, Unproven Compounding w/ Kyle Grieve & Shawn O'Malley
Nov 12, 2026
TIP859: Mercado Libre ($MELI): We Doubled Down on Meli w/ Daniel Mahncke & Shawn O'Malley
Nov 8, 2026
Listen ad-free on Castria